Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000214198 | SCV000277803 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001705227 | SCV000731201 | likely benign | not provided | 2019-04-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV004563210 | SCV000830370 | likely benign | Familial adenomatous polyposis 1 | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004563210 | SCV005082859 | benign | Familial adenomatous polyposis 1 | 2024-04-04 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV003947729 | SCV004757811 | likely benign | APC-related disorder | 2019-11-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |